Skip to content

Medication Reviews ReDirected (MedReDi): Acute Coronary Syndrome as an Indication for Home Medicine Review, a Randomised Controlled Trial

In acute coronary syndrome patients discharged from hospital, does a home medicine review increase the percentage of patients taking all four guideline-recommended medications compared to usual care?

Status
Suspended
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000452998
Acronym
MedReDi
Enrollment
465
Registered
2011-05-03
Start date
2012-04-25
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Can home medicine reviews improve health outcomes when directed at patients after acute coronary syndrome.

Interventions

Home Medicine Review - a service provided by specifically trained pharmacists on request from a patient's GP. Following GP referral, the patient's community pharmacist selects an accredited pharmacist to complete the review and passes on the referral. The accredited pharmacist visits the patient, preferably in their home and discusses their current methods for managing their medication. From this visit, the accredited pharmacist compiles a report for the GP, detailing the patient's actual list o

Home Medicine Review - a service provided by specifically trained pharmacists on request from a patient's GP. Following GP referral, the patient's community pharmacist selects an accredited pharmacist to complete the review and passes on the referral. The accredited pharmacist visits the patient, preferably in their home and discusses their current methods for managing their medication. From this visit, the accredited pharmacist compiles a report for the GP, detailing the patient's actual list of medications at their home and how they were taking them as well as any recommendations for improvement of the medication regimen. In this trial we will be using acute coronary syndrome as a referral trigger for this process. This process should occur at or near two months post-discharge. In this trial the accredited pharmacists completing the reviews will be given additional training and a brief assessment quiz on evidence-based management of acute coronary syndrome (ACS) and how to include this into an ACS-specific home medicine review. If an accredited pharmacist is not available or not willing to undertake the education then a study pharmacist who has also undergone the training package will complete the review.

Sponsors

Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Sandy Bay
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Any patients admited with a diagnosis of acute coronary syndrome or equivalent event, including: unstable angina, non-ST elevation AMI, ST elevation AMI, AMI, or heart attack.

Exclusion criteria

Cognitive decline to the extent that it may prevent ability to obtain informed consent directly from the patient. Palliative patients with a life expectancy less than 18 months. Discharge destination other than "home". Non-Medicare eligible patients, eg. international patients.

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 26, 2026